BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Dubai
BEGIN:STANDARD
TZOFFSETFROM:+0400
TZOFFSETTO:+0400
TZNAME:+04
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241105
DTEND;VALUE=DATE:20241110
DTSTAMP:20260403T223338
CREATED:20240923T190008Z
LAST-MODIFIED:20241024T183125Z
UID:10000811-1730764800-1731196799@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN at ASHG 2024
DESCRIPTION:Meet QIAGEN at the 2024 American Society of Human Genetics (ASHG) Annual Meeting\nThis year at the 2024 American Society of Human Genetics (ASHG) Annual Meeting\, QIAGEN will showcase our Sample to Insight solutions for human genetics and inherited disease applications. From digital PCR technologies and actionable exome panels to one of the fastest and cheapest secondary analysis solutions in the market and industry-leading variant interpretation and reporting software trusted to analyze and interpret over 4 million NGS patient test cases worldwide\, our Sample to Insight solutions are revolutionizing genetic testing. \nLearn more and schedule a VIP meeting with our experts at ASHG 2024 here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-at-ashg-2024/
CATEGORIES:Clinical,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/pexels-noelace-16108565-scaled-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241106T130000
DTEND;TZID=UTC:20241106T150000
DTSTAMP:20260403T223338
CREATED:20241015T172634Z
LAST-MODIFIED:20241024T183126Z
UID:10000814-1730898000-1730905200@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN IPA new user training
DESCRIPTION:Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA. \nYou’ll learn how to: \n\nUpload multiple dataset types (e.g.\, RNA-seq\, proteomics\, metabolomics) and perform interactive core/pathway analysis in IPA\nInterpret different results\, including pathways\, key regulators\, impact on biological functions/diseases and more\nCompare different experimental conditions (e.g.\, single-cell clusters\, disease types) and identify similarities and contrasts\nGenerate a network for hypothesis generation\, even without a dataset or experimental design\n\nAlready have an IPA license? Install IPA and start using it now. \nLearn more about IPA or request a free trial.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ipa-new-user-training-3/
LOCATION:Virtual - Americas - EST\, United States
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241107T110000
DTEND;TZID=UTC:20241107T130000
DTSTAMP:20260403T223338
CREATED:20240923T171152Z
LAST-MODIFIED:20241024T183121Z
UID:10000808-1730977200-1730984400@staging.digitalinsights.supremeclients.com
SUMMARY:Exclusive Interactive Workshop: Master Clinical Variant Interpretation with QCI Interpret for Oncology
DESCRIPTION:An exclusive hands-on workshop to try QCI Interpret for Oncology\nFor US-based labs interested in learning more about QCI Interpret for Oncology\, QIAGEN’s clinical decision support software for variant interpretation and reporting\, we are hosting an exclusive\, interactive virtual workshop where you can access and demo the software for free. Each attendee will be given a temporary license and a VCF file to run a case on the industry-leading software. Through a guided session\, you will be able to see first-hand how QCI Interpret works\, with full exploration of the software’s capabilities and features. \nIn this workshop\, you will see how QCI Interpret: \n• Dynamically computes pathogenicity and actionability based on the ACMG and AMP/ASCO/CAP guidelines for every variant in all cancer types with full transparency. \n• Provides access to over 500\,000 pre-formulated\, oncologist-reviewed variant interpretation summaries to build customizable\, oncologist-ready reports. \n• Effortlessly streamlines case reviews by automatically selecting reportable variants\, along with tailored treatments and trials. \nOnly 40 spots available. Must apply by October 25\, 2024. \nThis workshop is an exclusive event limited to a select number of participants. To register\, you must provide a work email and be selected by QIAGEN to attend. The workshop will be hosted on a US server and no customer data will be involved. \nLearn more and register here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/exclusive-interactive-workshop-master-clinical-variant-interpretation-with-qci-interpret-for-oncology/
CATEGORIES:Clinical,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_5731_NGS_QCI_s-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Dubai:20241107T130000
DTEND;TZID=Asia/Dubai:20241107T143000
DTSTAMP:20260403T223338
CREATED:20241015T174009Z
LAST-MODIFIED:20241024T183126Z
UID:10000815-1730984400-1730989800@staging.digitalinsights.supremeclients.com
SUMMARY:Support Session for IPA Certification
DESCRIPTION:Join us for a 90-minute LIVE group session designed to address different technical questions regarding IPA certification. QIAGEN IPA scientists will answer different IPA related technical questions and clarify various topics per requests of IPA certification participants. If possible\, please register for this session and let us know your questions by November 4\, 2024. \nPlease note: \n\nWe strongly encourage you to submit your questions ahead of time through this registration form.\nWhile questions submitted through this registration ahead of time will be prioritized\, we will try to answer as many questions as possible in these 90 min.\nThe purpose of this session is NOT for QIAGEN scientist to answer IPA certification exam questions but rather explain concepts surrounding these questions. Example\, for exam question asking how many molecules are mapped vs unmapped in the exam dataset\, the QIAGEN scientist will not give you the number but if asked\, will go over relevant steps of the data upload process.\nOnly those who signed up for IPA certification are invited to this session.\n\nQuestions we have so far: \n\nExplain course structure and exam related details.\nGo over recent update (RNA-seq analysis portal\, new pathways\, GWAS etc.) and cover this in context of this course.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/support-session-for-ipa-certification/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241112T130000
DTEND;TZID=America/Halifax:20241112T143000
DTSTAMP:20260403T223338
CREATED:20240919T155400Z
LAST-MODIFIED:20241024T183120Z
UID:10000806-1731416400-1731421800@staging.digitalinsights.supremeclients.com
SUMMARY:Discover biomarkers\, validate targets and identify variants with QDI software
DESCRIPTION:Learn how to leverage solutions from QIAGEN Digital Insights to discover biomarkers\, validate targets\, and identify variants. \nAttendees will learn to: \n\nLocate public studies of interest using OmicSoft DiseaseLand\nInvestigate expression of genes of interest across different treatments\, disease states\, etc.\nIdentify variants of interest for candidate biomarkers and targets using Human Gene Mutation Database (HGMD)\nLeverage the QIAGEN Knowledgebase in Ingenuity Pathway Analysis (IPA) to explore and extend findings from OmicSoft DiseaseLand and HGMD\nAccess data from OmicSoft\, HGMD and IPA in ways that are helpful for data scientists
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/discover-biomarkers-validate-targets-and-identify-variants-with-qdi-software/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1188_7_QDI_QDI_OmicSoft.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241113T100000
DTEND;TZID=America/New_York:20241113T110000
DTSTAMP:20260403T223338
CREATED:20241023T175035Z
LAST-MODIFIED:20241024T183129Z
UID:10000821-1731492000-1731495600@staging.digitalinsights.supremeclients.com
SUMMARY:Webinar: Pharmacogenomics - One tool to decode drug response to variation in the genome
DESCRIPTION:Each year\, more than 134 million patients experience adverse drug events\, causing 2.4 million deaths worldwide. What if there was a better way to develop and prescribe safer\, more effective drugs based on the unique genetic information of every individual? \nIn this webinar\, learn about a game-changing solution for labs and pharmaceutical companies to rapidly and confidently translate complex pharmacogenomics (PGx) data into evidence-backed insights to inform therapeutic outcomes. QIAGEN Pharmacogenomic Insights (PGXI) is a new expert-curated knowledgebase solution that provides comprehensive access to verified and up-to-date data from multiple PGx sources\, including the FDA\, CPIC\, DPWG\, PharmVar\, and PubMed. Built upon a legacy platform used to deliver more than 1.6 million PGx annotations for more than 250 clinical research laboratories\, PGXI seamlessly integrates into existing or new workflows to automate the annotation of PGx data from all platforms\, including NGS and arrays. Within minutes\, users can retrieve a custom output of relevant information\, including relevant conditions associated with queried genes of interest\, relevant drug-gene associations\, and curated literature evidence for alleles in question. \nIn this webinar\, you will learn: \n\nHow PGXI can help your lab efficiently and consistently identify medications associated with adverse effects.\nWhat expert-curated content sources are available in PGXI\, eliminating the need to consult multiple databases and saving you significant time and money.\nHow to use PGXI to seamlessly scale your PGXI workflow and stay at the cutting edge of PGx research.\n\nPlus\, if eligible\, webinar attendees can try PGXI for free with an exclusive trial offer from QIAGEN. There’s an easier and faster way to translate PGx data into insights. Don’t miss this opportunity to elevate and transform your PGx program. \nLearn more and register here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/webinar-a-game-changer-for-pharmacogenomics-one-tool-to-decode-drug-response-to-variation-in-the-genome/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_1419_4_QDI_QCI_PGXI_Launch.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241114T130000
DTEND;TZID=America/Halifax:20241114T143000
DTSTAMP:20260403T223338
CREATED:20240919T162936Z
LAST-MODIFIED:20241024T183120Z
UID:10000807-1731589200-1731594600@staging.digitalinsights.supremeclients.com
SUMMARY:Checkpoint inhibitor and immuno-oncology investigation leveraging curated high-quality public ‘omics data
DESCRIPTION:While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data\, such investigation is hindered by the difficulty in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high-quality curated genomic repositories such as QIAGEN OmicSoft Lands immediately allows in-depth investigations across diverse data sources (GEO\, CPTAC\, TCGA\, GTEx and more) to discover and validate candidate checkpoint inhibitor drug targets and biomarkers. \nYou will learn how to do the following in the graphical user interface and through APIs: \n\nEasily identify relevant samples using extensive manually curated clinical metadata\nVisualize and identify checkpoint inhibition biology-related drug target and biomarkers expression patterns using expression data (RNA-seq\, scRNA-seq\, proteomics etc.)\nReveal how the expression of a group of biomarkers (or genes/proteins of interest) correlates in normal and disease tissue
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/checkpoint-inhibitor-and-immuno-oncology-investigation-leveraging-curated-high-quality-public-omics-data/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_1063_9_OmicSoft-Single-Cell-Lands_028687_16x9-1-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241119T080000
DTEND;TZID=UTC:20241123T170000
DTSTAMP:20260403T223338
CREATED:20240923T190720Z
LAST-MODIFIED:20241024T183125Z
UID:10000812-1732003200-1732381200@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN at AMP 2024
DESCRIPTION:Meet QIAGEN at the 2024 Association for Molecular Pathology (AMP) Annual Meeting\nThis year at the 2024 Association for Molecular Pathology (AMP) Annual Meeting\, QIAGEN will showcase our barrier-breaking Sample to Insight Oncology solution. Combining targeted DNA and multimodal pan-cancer panels\, one of the fastest and cheapest secondary analysis solutions in the market\, and industry-leading variant interpretation and reporting software trusted to analyze and interpret over 4 million NGS patient test cases worldwide\, our Sample to Insight Oncology solution is revolutionizing precision oncology testing. \nLean more and schedule a VIP meeting with our experts at AMP 2024 here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-at-amp-2024/
CATEGORIES:Clinical,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_1385_7_QDI_QCI_Skyline_Vancouver_pexels2416602.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Dubai:20241119T130000
DTEND;TZID=Asia/Dubai:20241119T143000
DTSTAMP:20260403T223338
CREATED:20241015T174847Z
LAST-MODIFIED:20241024T183126Z
UID:10000816-1732021200-1732026600@staging.digitalinsights.supremeclients.com
SUMMARY:Investigating genomic variants using QIAGEN CLC Genomics Workbench\, QCI Interpret-Translational (QCII-T)\, and Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Discovery of new genes implicated in hereditary diseases or cancer progression is challenging and advancing rapidly with an increase in the amount of cohort data to analyze from next generation sequencing (NGS) data to associations between gene variants and diseases\, and finally to biological mechanisms of these gene variants. Combining QIAGEN CLC Genomics Workbench\, QCII-T\, and IPA\, scientists can analyze sequencing data obtained from a variety of NGS technologies\, annotate gene variants using the world’s most comprehensive and up-to-date curated scientific evidence\, and find biological connections in gene variants with manually curated scientific findings. Get valuable and reliable insights for your research project and speed up your discoveries by using a streamlined NGS analysis workflow. \nIn this webinar\, attendees will have the opportunity to: \n\nLearn how to import whole genome or exome sequencing data into QIAGEN CLC Genomics Workbench and use the ultra-fast LightSpeed Module that delivers end-to-end NGS FASTQ to VCF pipeline;\nExplore capabilities in QCII-T which can enable scientists to accelerate discoveries from hereditary or tumor cohort analyses to find associations between gene variants and diseases;\nLearn how to use IPA and its manually curated content among other integrated scientific evidence to uncover novel biological mechanisms underlying these gene variants.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/investigating-genomic-variants-using-qiagen-clc-genomics-workbench-qci-interpret-translational-qcii-t-and-ingenuity-pathway-analysis-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Dubai:20241120T130000
DTEND;TZID=Asia/Dubai:20241120T140000
DTSTAMP:20260403T223338
CREATED:20241015T175057Z
LAST-MODIFIED:20241023T210126Z
UID:10000817-1732107600-1732111200@staging.digitalinsights.supremeclients.com
SUMMARY:New feature: Insights with IPA Interpret
DESCRIPTION:Unlock actionable insights in your biological data by streamlining your data interpretation with IPA Interpret. \nThe newest feature of your trusted pathway analysis software\, QIAGEN IPA\, includes: \n\nContent powered by IPA's extensive\, manually curated knowledge base and aided by AI\nEasy-to-share reports and updated visualizations to facilitate collaboration and dissemination of research findings\nEasy access from your favorite web browser\, no additional software or hardware needed
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-feature-insights-with-ipa-interpret/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Dubai:20241121T130000
DTEND;TZID=Asia/Dubai:20241121T140000
DTSTAMP:20260403T223338
CREATED:20241015T175251Z
LAST-MODIFIED:20241023T210055Z
UID:10000818-1732194000-1732197600@staging.digitalinsights.supremeclients.com
SUMMARY:New feature: Navigating datasets with OmicSoft Explorer
DESCRIPTION:Meet OmicSoft Explorer\, a new feature included with your QIAGEN IPA/OmicSoft subscriptions. See how you can find ‘omics datasets to inform your next experiments or support your grant proposals. \nWith OmicSoft Explorer\, you can: \n\nSearch over 10\,000 disease-relevant datasets for clinical\, in vitro\, normal tissue and more\nReveal top differentially expressed genes from over 200\,000 experiments\nDiscover experiments that include your gene of interest\nExplore underlying biology through IPA Interpret
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-feature-navigating-datasets-with-omicsoft-explorer/
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250107T130000
DTEND;TZID=America/New_York:20250107T150000
DTSTAMP:20260403T223338
CREATED:20241218T221447Z
LAST-MODIFIED:20241218T221447Z
UID:10000822-1736254800-1736262000@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN IPA new user training
DESCRIPTION:Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA. \nYou’ll learn to: \n\nUpload multiple dataset types (e.g.\, RNA-seq\, proteomics\, metabolomics) and perform interactive core/pathway analysis in IPA\nLearn how to interpret different results\, including pathways\, key regulators\, impact on biological functions/diseases and more\nCompare different experimental conditions (e.g.\, single-cell clusters\, disease types) and identify similarities and contrasts\nGenerate a network for hypothesis generation\, even without a dataset or experimental design\n\nAlready have an IPA license? Install IPA and start using it now. \nLearn more about IPA or request a free trial. \nRegister for the event.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ipa-new-user-training-5/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250109T130000
DTEND;TZID=America/New_York:20250109T143000
DTSTAMP:20260403T223338
CREATED:20241218T221811Z
LAST-MODIFIED:20241218T222329Z
UID:10000823-1736427600-1736433000@staging.digitalinsights.supremeclients.com
SUMMARY:Support Session for IPA Certification
DESCRIPTION:Join us for a 90-minute LIVE group session designed to address different technical questions regarding IPA certification. QIAGEN IPA scientists will answer different IPA related technical questions and clarify various topics per requests of IPA certification participants.\n \nPlease note: \n\nWe strongly encourage you to submit your questions ahead of time through this registration form.\nWhile questions submitted through this registration ahead of time will be prioritized\, we will try to answer as many questions as possible in these 90 min.\nThe purpose of this session is NOT for QIAGEN scientist to answer IPA certification exam questions but rather explain concepts surrounding these questions. For example\, if you ask how many molecules are mapped vs unmapped in the exam dataset\, the QIAGEN scientist will go over relevant steps of the data upload process rather than give you the number directly.\nOnly those who signed up for IPA certification are invited to this session.\nQuestions we have so far:\n\nExplain course structure and exam related details.\n\n\nGo over recent update (RNA-seq analysis portal\, new pathways\, GWAS etc.) and cover this in context of this course.\n\nRegister for the event.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/support-session-for-ipa-certification-3/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250114T130000
DTEND;TZID=America/New_York:20250114T143000
DTSTAMP:20260403T223338
CREATED:20241218T222028Z
LAST-MODIFIED:20241218T222323Z
UID:10000824-1736859600-1736865000@staging.digitalinsights.supremeclients.com
SUMMARY:Sanger sequencing\, alignment\, cloning\, primer design and more using QIAGEN CLC Main and Genomics Workbench
DESCRIPTION:This training will be relevant to both QIAGEN Main and Genomics workbench users and prospects who are interested in below analytics. \n\nAlignment and tree construction\nSanger sequencing analysis\nCloning and primer design\nOther molecular biology tools\n\nRegister for the event.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/sanger-sequencing-alignment-cloning-primer-design-and-more-using-qiagen-clc-main-and-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250116T130000
DTEND;TZID=America/New_York:20250116T143000
DTSTAMP:20260403T223338
CREATED:20241218T222418Z
LAST-MODIFIED:20241218T222550Z
UID:10000825-1737032400-1737037800@staging.digitalinsights.supremeclients.com
SUMMARY:Discoveries from deeply curated TCGA expression data using OmicSoft Studio
DESCRIPTION:While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data sources such as The Cancer Genome Atlas (TCGA)\, such investigation is hindered by difficulties in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high-quality curated genomic repositories such as QIAGEN OmicSoft Lands immediately allows in-depth investigations across diverse data sources (GEO\, CPTAC\, TCGA\, GTEx and more) to discover and validate candidate checkpoint inhibitor drug targets and biomarkers. \nYou will discover how to: \n\nUse sample IDs to create a custom dataset from the deeply curated TCGA collection available within OmicSoft Lands\nEasily download count information for each sample across all genes and create a local or server project\nCalculate differential expression using metadata of interest\nGenerate volcano\, PCA/PCOA\, heatmap\, expression and other plots for scientific discoveries\nUpload the data to Ingenuity Pathway Analysis for hypothesis generation\n\nRegister for the event.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/discoveries-from-deeply-curated-tcga-expression-data-using-omicsoft-studio/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_1212_8_QDI_QDI_BKB_Original_62142.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250120T140000
DTEND;TZID=America/New_York:20250120T153000
DTSTAMP:20260403T223338
CREATED:20241218T222750Z
LAST-MODIFIED:20241218T222750Z
UID:10000826-1737381600-1737387000@staging.digitalinsights.supremeclients.com
SUMMARY:Single-cell RNA-seq\, cell hashing and spatial transcriptomics
DESCRIPTION:In this training\, you will learn how to analyze and interpret your own single cell RNA-seq data using QIAGEN CLC Genomics Workbench starting with either FASTQ or matrix files. \nUsing CLC Genomics Workbench\, you will learn how to perform secondary analysis on your single cell RNA-seq data. Specifically\, you will learn how to: \n\nImport your raw FASTQ or processed cell-matrix files.\nUse pre-configured but customizable pipelines/workflows for single cell RNA-seq data.\nGenerate high resolution visuals and other files from your analysis for publications and biopharmaceutical discoveries\, including dimension reduction (UMAP\, t-SNE) plots\, differential expression table for clusters\, cell types or both\, heat maps\, dot plots and violin plots.\nLearn how to use “Create Cell Annotations from Hashtags” for cell hashing (i.e.\, CITE-seq).\nDive into spatial transcriptomic analysis\, the latest feature in the single cell RNA-seq module.\n\nRegister for the event.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/single-cell-rna-seq-cell-hashing-and-spatial-transcriptomics-4/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250121T130000
DTEND;TZID=America/New_York:20250121T140000
DTSTAMP:20260403T223338
CREATED:20241218T222943Z
LAST-MODIFIED:20241218T222943Z
UID:10000827-1737464400-1737468000@staging.digitalinsights.supremeclients.com
SUMMARY:Identifying critical drug-to-disease pathways using high-quality curated literature and ‘omics data
DESCRIPTION:In the drug discovery pipeline\, evaluating multiple pathways between a drug target and disease is crucial for identifying potential therapeutic approaches. By examining overlapping pathways between competing drugs\, researchers can uncover novel drug targets\, while isoform-specific findings may elucidate unexpected clinical trial outcomes. Filtering these pathways with real-world expression and proteomics data is essential to validate new hypotheses and avoid pursuing non-viable leads. \nLeveraging tools such as Neo4j\, Python\, and R\, powered by curated databases like the QIAGEN Biomedical Knowledge Base and OmicSoft Lands\, enables scientists to efficiently explore potential mechanisms of action during both target discovery and later stages of drug development. \nAttendees will learn to: \n\nApply pathfinding algorithms to navigate our comprehensive knowledge graph.\nQualify drug candidates using curated scRNA-Seq expression data and detailed cell type annotations.\nExpand\, filter\, prioritize\, and refine lists of biomarkers and drug targets through various advanced approaches.\n\nRegister for the event.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/identifying-critical-drug-to-disease-pathways-using-high-quality-curated-literature-and-omics-data/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_1212_8_QDI_QDI_BKB_Original_62142.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250123T130000
DTEND;TZID=America/New_York:20250123T140000
DTSTAMP:20260403T223338
CREATED:20241218T223130Z
LAST-MODIFIED:20241218T223130Z
UID:10000828-1737637200-1737640800@staging.digitalinsights.supremeclients.com
SUMMARY:Tissue-specific target identification using QIAGEN OmicSoft high-quality ‘omics data
DESCRIPTION:Disease pathogenesis is often context-dependent\, specifically on tissue expression profiles within a given disease context. However\, tissue expression profile of drug targets or potential targets is often difficult to ascertain. In this webinar\, we will dive deep into the wealth of available deeply curated high quality ‘omics data (RNA-seq\, scRNA-seq and more) in the OmicSoft Lands database using APIs to achieve the following: \n\nDemonstrate how to obtain a disease gene signature of interest.\nCompare the constitutive expression profile of that gene set across different tissues.\nFind tissues with similar expression profiles.\nGenerate a hypothesis relating two tissue specific diseases to each other for the purpose of indication expansion.\n\nRegister for the event.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/tissue-specific-target-identification-using-qiagen-omicsoft-high-quality-omics-data/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_1212_8_QDI_QDI_BKB_Original_62142.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250831T080000
DTEND;TZID=UTC:20250831T170000
DTSTAMP:20260403T223338
CREATED:20250611T224127Z
LAST-MODIFIED:20250611T230051Z
UID:10000830-1756627200-1756659600@staging.digitalinsights.supremeclients.com
SUMMARY:Test event 1
DESCRIPTION:Some quick page content so we can see the difference in output.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/test-event-1/
CATEGORIES:Webinar
ORGANIZER;CN="Test organizer 1":MAILTO:test@test.test
END:VEVENT
END:VCALENDAR